Ophthalmic Oncology

Ophthalmic Oncology

Latest News

Close up of skin cancer

Previous Tx in Metastatic Melanoma May Cut Response to ACT TIL

Previous treatment with anti-programmed cell death-1 (aPD-1) therapy or targeted molecular therapy is associated with a lower objective response rate to adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes (TILs) in metastatic melanoma.
Next post in Ophthalmic Oncology